The genetic alteration status of YY1 has been previously reported in a pan-cancer context, and has demonstrated effects of YY1 mutation on gene expression in multiple myeloma and uterine cancer, as well as on YY1 expression in cervix cancer, head and neck cancer, lung squamous cell carcinoma, and melanoma [52]. Here, YY1 is linked to uterine cancer.